Latest Microba Life Sciences (ASX:MAP) News
Page 3
Page 3 of 4
Microba Accelerates Core Test Growth with 90% Volume Surge and $2.1M Revenue
29 Jan 2026
Microba Boosts Innovation with $3 Million R&D Tax Refund
3 Dec 2025
Microba Accelerates Growth with New Features and Eyes US Market Breakthrough
28 Oct 2025
Microba Surges 145% in Test Volumes, Eyes FY26 Break-Even
28 Oct 2025
Microba Advances Diagnostics with 30% Revenue Growth and UK Expansion
26 Aug 2025
Microba Accelerates Growth with Record Q4 Sales and Eyes FY26 Break-Even
22 July 2025
Microba Drives Record Test Sales and Clinical Adoption Amid Strategic Shift
22 July 2025
Microba Launches $2M Share Purchase Plan with Free Options to Fuel Growth
27 June 2025
Microba Life Sciences Launches $14.5M Capital Raise to Accelerate Microbiome Test Rollout
27 June 2025
Microba Life Sciences Resumes Trading After Capital Raise Announcement
23 June 2025
Microba Secures $12.5M Equity Raise Led by Sonic Healthcare to Accelerate UK Expansion
23 June 2025
Microba Secures $14.5M, Narrows FY25 Revenue Guidance, Signs UK Lab Deal
23 June 2025